首页 > 最新文献

medRxiv : the preprint server for health sciences最新文献

英文 中文
Clinical Progression on CDR-SB © : Progression Free Time at Each 0.5-unit Level in Dominantly Inherited and Sporadic Alzheimer's Disease Populations. CDR-SB © 的临床进展:显性遗传和散发性阿尔茨海默病人群中每 0.5 个单位水平的无进展时间。
Pub Date : 2025-02-20 DOI: 10.1101/2025.02.17.25322322
Guoqiao Wang, Yan Li, Eric McDade, Chengjie Xiong, Sarah M Hartz, Randall J Bateman, John C Morris, Lon S Schneider

Introduction: CDR-SB is a reliable and clinically meaningful composite for assessing treatment effects in Alzheimer's disease (AD) clinical trials. Small CDR-SB differences at the end of a trial often lead to controversy in deriving clinically meaningful interpretations.

Methods: We estimated progression-free time participants remained at each 0.5-unit CDR-SB increment in dominantly inherited AD (DIAD) and sporadic AD populations, evaluating its potential as an alternative measure of treatment effects.

Results: Progression-free time is longer at CDR-SB ≤ 2.0 (1-2 years) and shorter at CDR-SB ≥ 5 (0.33 or less) in the ADNI cohort. The DIAD cohort showed similar but shorter times. Using progression-free time, continuous lecanemab treatment for three years is estimated to delay disease progression by 0.7 years in the sporadic population.

Discussion: Progression-free time provides a benchmark for expressing clinical progression and treatment effects and can be applied particularly during open-label extensions and singlearm trials without placebo comparisons.

{"title":"Clinical Progression on CDR-SB <sup>©</sup> : Progression Free Time at Each 0.5-unit Level in Dominantly Inherited and Sporadic Alzheimer's Disease Populations.","authors":"Guoqiao Wang, Yan Li, Eric McDade, Chengjie Xiong, Sarah M Hartz, Randall J Bateman, John C Morris, Lon S Schneider","doi":"10.1101/2025.02.17.25322322","DOIUrl":"https://doi.org/10.1101/2025.02.17.25322322","url":null,"abstract":"<p><strong>Introduction: </strong>CDR-SB is a reliable and clinically meaningful composite for assessing treatment effects in Alzheimer's disease (AD) clinical trials. Small CDR-SB differences at the end of a trial often lead to controversy in deriving clinically meaningful interpretations.</p><p><strong>Methods: </strong>We estimated progression-free time participants remained at each 0.5-unit CDR-SB increment in dominantly inherited AD (DIAD) and sporadic AD populations, evaluating its potential as an alternative measure of treatment effects.</p><p><strong>Results: </strong>Progression-free time is longer at CDR-SB ≤ 2.0 (1-2 years) and shorter at CDR-SB ≥ 5 (0.33 or less) in the ADNI cohort. The DIAD cohort showed similar but shorter times. Using progression-free time, continuous lecanemab treatment for three years is estimated to delay disease progression by 0.7 years in the sporadic population.</p><p><strong>Discussion: </strong>Progression-free time provides a benchmark for expressing clinical progression and treatment effects and can be applied particularly during open-label extensions and singlearm trials without placebo comparisons.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and Predictors of Adolescent Worry for School Gun Violence In the United States: Findings from a Nationally Representative Study.
Pub Date : 2025-02-20 DOI: 10.1101/2025.02.18.25322472
Danielle Kirkland, Tsung-Chieh Fu, Debby Herbenick, Devon J Hensel

Purpose: While school gun violence (SGV) incidents in the United States (U.S.) have risen sharply over the past decade, limited research has examined adolescent worries about SGV. We examined the frequency and correlates of SGV worry in a U.S. nationally representative sample of adolescents.

Methods: Data were from adolescent participants (14-17 years; N = 1017) in the 2022 National Survey of Sexual Health and Behavior, a nationally representative study of sexual health experiences of people in the U.S. SGV worry was a single 5-point item (not at all worried - extremely worried). We used both weighted descriptive statistics to examine SGV frequency and random intercept mixed effects ordinal regression to examine demographic and background impact on SGV worry.

Results: Nearly 75% of adolescents reported some degree of SGV worry; of these, one in five were very or extremely worried. SGV worry was significantly higher for adolescents in younger grades and among racial/ethnic minority youth, as well as for cisgender female and gender minority teens. Adolescents in higher income homes were less worried about SGV. Both teens living in metropolitan locations and teens who reported higher anxiety in the past two weeks noted higher SGV worry.

Conclusions: U.S. adolescents have a substantial level of worry about school gun violence. Structural interventions are needed to reduce SGV itself. Moreover, because there are detrimental long-term impacts of prolonged worry, targeted interventions are important for reaching those who are at greatest worry risk, including lower income, race/ethnic minority and gender minority teens.

Implications and conclusions: Three out of every four adolescents in the United States worry about being a victim of school gun violence. Structural interventions to both reduce SGV itself and to reach adolescents at greatest risk for SGV worry are warranted.

{"title":"Frequency and Predictors of Adolescent Worry for School Gun Violence In the United States: Findings from a Nationally Representative Study.","authors":"Danielle Kirkland, Tsung-Chieh Fu, Debby Herbenick, Devon J Hensel","doi":"10.1101/2025.02.18.25322472","DOIUrl":"https://doi.org/10.1101/2025.02.18.25322472","url":null,"abstract":"<p><strong>Purpose: </strong>While school gun violence (SGV) incidents in the United States (U.S.) have risen sharply over the past decade, limited research has examined adolescent worries about SGV. We examined the frequency and correlates of SGV worry in a U.S. nationally representative sample of adolescents.</p><p><strong>Methods: </strong>Data were from adolescent participants (14-17 years; N = 1017) in the 2022 National Survey of Sexual Health and Behavior, a nationally representative study of sexual health experiences of people in the U.S. SGV worry was a single 5-point item (not at all worried - extremely worried). We used both weighted descriptive statistics to examine SGV frequency and random intercept mixed effects ordinal regression to examine demographic and background impact on SGV worry.</p><p><strong>Results: </strong>Nearly 75% of adolescents reported some degree of SGV worry; of these, one in five were very or extremely worried. SGV worry was significantly higher for adolescents in younger grades and among racial/ethnic minority youth, as well as for cisgender female and gender minority teens. Adolescents in higher income homes were less worried about SGV. Both teens living in metropolitan locations and teens who reported higher anxiety in the past two weeks noted higher SGV worry.</p><p><strong>Conclusions: </strong>U.S. adolescents have a substantial level of worry about school gun violence. Structural interventions are needed to reduce SGV itself. Moreover, because there are detrimental long-term impacts of prolonged worry, targeted interventions are important for reaching those who are at greatest worry risk, including lower income, race/ethnic minority and gender minority teens.</p><p><strong>Implications and conclusions: </strong>Three out of every four adolescents in the United States worry about being a victim of school gun violence. Structural interventions to both reduce SGV itself and to reach adolescents at greatest risk for SGV worry are warranted.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comorbidity analysis and clustering of endometriosis patients using electronic health records.
Pub Date : 2025-02-19 DOI: 10.1101/2025.02.13.25322244
Umair Khan, Tomiko T Oskotsky, Bahar D Yilmaz, Jacquelyn Roger, Ketrin Gjoni, Juan C Irwin, Jessica Opoku-Anane, Noémie Elhadad, Linda C Giudice, Marina Sirota

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterogeneity are limited. In this retrospective case-control study, we analyzed comorbidities from over forty thousand endometriosis patients across six University of California medical centers using de-identified electronic health record (EHR) data. We found hundreds of conditions significantly associated with endometriosis, including genitourinary disorders, neoplasms, and autoimmune diseases, with strong replication across datasets. Clustering analyses identified patient subpopulations with distinct comorbidity patterns, including psychiatric and autoimmune conditions. This study provides a comprehensive analysis of endometriosis comorbidities and highlights the heterogeneity within the patient population. Our findings demonstrate the utility of EHR data in uncovering clinically meaningful patterns and suggest pathways for personalized disease management and future research on biological mechanisms underlying endometriosis.

{"title":"Comorbidity analysis and clustering of endometriosis patients using electronic health records.","authors":"Umair Khan, Tomiko T Oskotsky, Bahar D Yilmaz, Jacquelyn Roger, Ketrin Gjoni, Juan C Irwin, Jessica Opoku-Anane, Noémie Elhadad, Linda C Giudice, Marina Sirota","doi":"10.1101/2025.02.13.25322244","DOIUrl":"10.1101/2025.02.13.25322244","url":null,"abstract":"<p><p>Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterogeneity are limited. In this retrospective case-control study, we analyzed comorbidities from over forty thousand endometriosis patients across six University of California medical centers using de-identified electronic health record (EHR) data. We found hundreds of conditions significantly associated with endometriosis, including genitourinary disorders, neoplasms, and autoimmune diseases, with strong replication across datasets. Clustering analyses identified patient subpopulations with distinct comorbidity patterns, including psychiatric and autoimmune conditions. This study provides a comprehensive analysis of endometriosis comorbidities and highlights the heterogeneity within the patient population. Our findings demonstrate the utility of EHR data in uncovering clinically meaningful patterns and suggest pathways for personalized disease management and future research on biological mechanisms underlying endometriosis.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11844609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole genome sequence-based association analysis of African American individuals with bipolar disorder and schizophrenia. 非裔美国人双相情感障碍和精神分裂症个体的全基因组序列关联分析。
Pub Date : 2025-02-19 DOI: 10.1101/2024.12.27.24319111
Runjia Li, Sarah A Gagliano Taliun, Kevin Liao, Matthew Flickinger, Janet L Sobell, Giulio Genovese, Adam E Locke, Rebeca Rothwell Chiu, Jonathon LeFaive, Jiongming Wang, Taylor Martins, Sinéad Chapman, Anna Neumann, Robert E Handsaker, Donna K Arnett, Kathleen C Barnes, Eric Boerwinkle, David Braff, Brian E Cade, Myriam Fornage, Richard A Gibbs, Karin F Hoth, Lifang Hou, Charles Kooperberg, Ruth J F Loos, Ginger A Metcalf, Courtney G Montgomery, Alanna C Morrison, Zhaohui S Qin, Susan Redline, Alexander P Reiner, Stephen S Rich, Jerome I Rotter, Kent D Taylor, Karine A Viaud-Martinez, Tim B Bigdeli, Stacey Gabriel, Sebastian Zollner, Albert V Smith, Goncalo Abecasis, Steve McCarroll, Michele T Pato, Carlos N Pato, Michael Boehnke, James Knowles, Hyun Min Kang, Roel A Ophoff, Jason Ernst, Laura J Scott

In studies of individuals of primarily European genetic ancestry, common and low-frequency variants and rare coding variants have been found to be associated with the risk of bipolar disorder (BD) and schizophrenia (SZ). However, less is known for individuals of other genetic ancestries or the role of rare non-coding variants in BD and SZ risk. We performed whole genome sequencing of African American individuals: 1,598 with BD, 3,295 with SZ, and 2,651 unaffected controls (InPSYght study). We increased power by incorporating 14,812 jointly called psychiatrically unscreened ancestry-matched controls from the Trans-Omics for Precision Medicine (TOPMed) Program for a total of 17,463 controls. To identify variants and sets of variants associated with BD and/or SZ, we performed single-variant tests, gene-based tests for singleton protein truncating variants, and rare and low-frequency variant annotation-based tests with conservation and universal chromatin states and sliding windows. We found suggestive evidence of BD association with single-variants on chromosome 18 and of lower BD risk associated with rare and low-frequency variants on chromosome 11 in a region with multiple BD GWAS loci, using a sliding window approach. We also found that chromatin and conservation state tests can be used to detect differential calling of variants in controls sequenced at different centers and to assess the effectiveness of sequencing metric covariate adjustments. Our findings reinforce the need for continued whole genome sequencing in additional samples of African American individuals and more comprehensive functional annotation of non-coding variants.

在对主要是欧洲遗传血统的个体的研究中,发现常见和低频变异以及罕见的编码变异与双相情感障碍(BD)和精神分裂症(SZ)的风险相关。然而,对于其他遗传祖先的个体或罕见的非编码变异在BD和SZ风险中的作用知之甚少。我们对非裔美国人进行了全基因组测序:1598名BD患者,3295名SZ患者和2651名未受影响的对照组(inpsyight研究)。我们通过纳入来自Trans-Omics for Precision Medicine (TOPMed)项目的14,812个联合称为精神病学未筛选的祖先匹配对照,总共有17,463个对照,从而增加了力量。为了确定与BD和/或SZ相关的变异和变异集,我们进行了单变异检测、基于基因的单蛋白截断变异检测,以及基于保守和普遍染色质状态和滑动窗口的罕见和低频变异注释检测。我们使用滑动窗口方法发现,在具有多个BD GWAS位点的区域,双相障碍与18号染色体上的单变异相关,与11号染色体上罕见和低频变异相关的双相障碍风险较低。我们还发现,染色质和保守状态测试可用于检测在不同中心测序的对照中变异的差异召唤,并评估测序度量协变量调整的有效性。我们的研究结果加强了对非裔美国人个体的更多样本进行全基因组测序和对非编码变异进行更全面功能注释的必要性。
{"title":"Whole genome sequence-based association analysis of African American individuals with bipolar disorder and schizophrenia.","authors":"Runjia Li, Sarah A Gagliano Taliun, Kevin Liao, Matthew Flickinger, Janet L Sobell, Giulio Genovese, Adam E Locke, Rebeca Rothwell Chiu, Jonathon LeFaive, Jiongming Wang, Taylor Martins, Sinéad Chapman, Anna Neumann, Robert E Handsaker, Donna K Arnett, Kathleen C Barnes, Eric Boerwinkle, David Braff, Brian E Cade, Myriam Fornage, Richard A Gibbs, Karin F Hoth, Lifang Hou, Charles Kooperberg, Ruth J F Loos, Ginger A Metcalf, Courtney G Montgomery, Alanna C Morrison, Zhaohui S Qin, Susan Redline, Alexander P Reiner, Stephen S Rich, Jerome I Rotter, Kent D Taylor, Karine A Viaud-Martinez, Tim B Bigdeli, Stacey Gabriel, Sebastian Zollner, Albert V Smith, Goncalo Abecasis, Steve McCarroll, Michele T Pato, Carlos N Pato, Michael Boehnke, James Knowles, Hyun Min Kang, Roel A Ophoff, Jason Ernst, Laura J Scott","doi":"10.1101/2024.12.27.24319111","DOIUrl":"10.1101/2024.12.27.24319111","url":null,"abstract":"<p><p>In studies of individuals of primarily European genetic ancestry, common and low-frequency variants and rare coding variants have been found to be associated with the risk of bipolar disorder (BD) and schizophrenia (SZ). However, less is known for individuals of other genetic ancestries or the role of rare non-coding variants in BD and SZ risk. We performed whole genome sequencing of African American individuals: 1,598 with BD, 3,295 with SZ, and 2,651 unaffected controls (InPSYght study). We increased power by incorporating 14,812 jointly called psychiatrically unscreened ancestry-matched controls from the Trans-Omics for Precision Medicine (TOPMed) Program for a total of 17,463 controls. To identify variants and sets of variants associated with BD and/or SZ, we performed single-variant tests, gene-based tests for singleton protein truncating variants, and rare and low-frequency variant annotation-based tests with conservation and universal chromatin states and sliding windows. We found suggestive evidence of BD association with single-variants on chromosome 18 and of lower BD risk associated with rare and low-frequency variants on chromosome 11 in a region with multiple BD GWAS loci, using a sliding window approach. We also found that chromatin and conservation state tests can be used to detect differential calling of variants in controls sequenced at different centers and to assess the effectiveness of sequencing metric covariate adjustments. Our findings reinforce the need for continued whole genome sequencing in additional samples of African American individuals and more comprehensive functional annotation of non-coding variants.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Carotid Plaque Progression and the Role of Intraplaque Hemorrhage: A Deep Learning-Based Analysis of Longitudinal Vessel Wall Imaging. 长期颈动脉斑块进展和斑块内出血的作用:基于深度学习的纵向血管壁成像分析。
Pub Date : 2025-02-19 DOI: 10.1101/2024.12.09.24318661
Yin Guo, Ebru Yaman Akcicek, Daniel S Hippe, SeyyedKazem HashemizadehKolowri, Xin Wang, Halit Akcicek, Gador Canton, Niranjan Balu, Duygu Baylam Geleri, Taewon Kim, Dean Shibata, Kaiyu Zhang, Xiaodong Ma, Marina S Ferguson, Mahmud Mossa-Basha, Thomas S Hatsukami, Chun Yuan

Background: Carotid atherosclerosis is a major contributor in the etiology of ischemic stroke. Although intraplaque hemorrhage (IPH) is known to increase stroke risk and plaque burden, its long-term effects on plaque dynamics remain unclear. This study aimed to evaluate the long-term impact of IPH on carotid plaque burden progression using deep learning-based segmentation on multi-contrast magnetic resonance vessel wall imaging (VWI).

Methods: Twenty-eight asymptomatic subjects with carotid atherosclerosis underwent an average of 4.7 ± 0.6 VWI scans over 5.8 ± 1.1 years. Deep learning pipelines were developed and validated to segment the carotid vessel walls and IPH. Bilateral plaque progression was analyzed using generalized estimating equations, and linear mixed-effects models evaluated long-term associations between IPH occurrence, IPH volume, and plaque burden (%WV) progression.

Results: IPH was detected in 23/50 of arteries. Of arteries without IPH at baseline, 11/39 developed new IPH that persisted, while 5/11 arteries with baseline IPH exhibited it throughout the study. Bilateral plaque growth was significantly correlated (r = 0.54, p < 0.001), but this symmetry was weakened with IPH presence. The progression rate for arteries without IPH was -0.001 %/year (p = 0.90). However, IPH presence or development at any point was associated with a 2.3% absolute increase in %WV on average (p < 0.001). The volume of IPH was also positively associated with increased %WV (p = 0.005).

Conclusions: Deep learning-based segmentation pipelines were utilized to identify IPH, quantify IPH volume, and measure their effects on carotid plaque burden during long-term follow-up. Findings demonstrated that IPH may persist for extended periods. While arteries without IPH demonstrated minimal progression under contemporary treatment, presence of IPH and greater IPH volume significantly accelerated long-term plaque growth.

背景:颈动脉粥样硬化是脑卒中的主要病因。虽然已知斑块内出血(IPH)会增加卒中风险和斑块负担,但其对斑块动力学的长期影响尚不清楚。目的:本研究旨在利用基于深度学习的多对比血管壁成像(VWI)分割技术,评估IPH对颈动脉斑块负荷进展的长期影响。方法:28例无症状颈动脉粥样硬化患者在5.8±1.1年内平均接受4.7±0.6次VWI扫描。深度学习管道分割颈动脉血管壁和IPH。使用广义估计方程分析双侧斑块进展,线性混合效应模型评估IPH发生、IPH体积(%HV)和斑块负担(%WV)进展之间的长期关系。结果:2例同侧IPH患者在随访中出现新的缺血性梗死。在23/50的动脉中检测到IPH。在基线时无IPH的动脉中,11/39发展为新的IPH并持续存在,而5/11基线IPH的动脉在整个研究过程中都表现出IPH。双侧斑块生长显著相关(r = 0.54, p < 0.001),但这种对称性随着IPH的存在而减弱。无IPH动脉的进展率为-0.001 %/年(p = 0.895)。然而,在任何时间点IPH的存在或发展与%WV绝对增加2.34%相关(p < 0.001),而%HV每增加2倍与%HV相关0.73% (p = 0.005)。结论:IPH可无症状持续较长时间。虽然没有IPH的动脉在当代治疗下表现出最小的进展,但IPH显著加速了长期斑块的生长。
{"title":"Long-Term Carotid Plaque Progression and the Role of Intraplaque Hemorrhage: A Deep Learning-Based Analysis of Longitudinal Vessel Wall Imaging.","authors":"Yin Guo, Ebru Yaman Akcicek, Daniel S Hippe, SeyyedKazem HashemizadehKolowri, Xin Wang, Halit Akcicek, Gador Canton, Niranjan Balu, Duygu Baylam Geleri, Taewon Kim, Dean Shibata, Kaiyu Zhang, Xiaodong Ma, Marina S Ferguson, Mahmud Mossa-Basha, Thomas S Hatsukami, Chun Yuan","doi":"10.1101/2024.12.09.24318661","DOIUrl":"10.1101/2024.12.09.24318661","url":null,"abstract":"<p><strong>Background: </strong>Carotid atherosclerosis is a major contributor in the etiology of ischemic stroke. Although intraplaque hemorrhage (IPH) is known to increase stroke risk and plaque burden, its long-term effects on plaque dynamics remain unclear. This study aimed to evaluate the long-term impact of IPH on carotid plaque burden progression using deep learning-based segmentation on multi-contrast magnetic resonance vessel wall imaging (VWI).</p><p><strong>Methods: </strong>Twenty-eight asymptomatic subjects with carotid atherosclerosis underwent an average of 4.7 ± 0.6 VWI scans over 5.8 ± 1.1 years. Deep learning pipelines were developed and validated to segment the carotid vessel walls and IPH. Bilateral plaque progression was analyzed using generalized estimating equations, and linear mixed-effects models evaluated long-term associations between IPH occurrence, IPH volume, and plaque burden (%WV) progression.</p><p><strong>Results: </strong>IPH was detected in 23/50 of arteries. Of arteries without IPH at baseline, 11/39 developed new IPH that persisted, while 5/11 arteries with baseline IPH exhibited it throughout the study. Bilateral plaque growth was significantly correlated (r = 0.54, p < 0.001), but this symmetry was weakened with IPH presence. The progression rate for arteries without IPH was -0.001 %/year (p = 0.90). However, IPH presence or development at any point was associated with a 2.3% absolute increase in %WV on average (p < 0.001). The volume of IPH was also positively associated with increased %WV (p = 0.005).</p><p><strong>Conclusions: </strong>Deep learning-based segmentation pipelines were utilized to identify IPH, quantify IPH volume, and measure their effects on carotid plaque burden during long-term follow-up. Findings demonstrated that IPH may persist for extended periods. While arteries without IPH demonstrated minimal progression under contemporary treatment, presence of IPH and greater IPH volume significantly accelerated long-term plaque growth.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11661346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142879322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Judged by your neighbors: Brain structural normativity profiles for large and heterogeneous samples. 由你的邻居判断:大样本和异质样本的大脑结构规范性概况。
Pub Date : 2025-02-19 DOI: 10.1101/2024.12.24.24319598
Ramona Leenings, Nils R Winter, Jan Ernsting, Maximilian Konowski, Vincent Holstein, Susanne Meinert, Jennifer Spanagel, Carlotta Barkhau, Lukas Fisch, Janik Goltermann, Malte Frank Gerdes, Dominik Grotegerd, Elisabeth Johanna Leehr, Annette Peters, Lilian Krist, Stefan N Willich, Tobias Pischon, Henry Völzke, Johannes Haubold, Hans-Ulrich Kauczor, Thoralf Niendorf, Maike Frederike Richter, Udo Dannlowski, Klaus Berger, Xiaoyi Jiang, James Cole, Nils Opel, Tim Hahn

The detection of norm deviations is fundamental to clinical decision making and impacts our ability to diagnose and treat diseases effectively. Current normative modeling approaches rely on generic comparisons and quantify deviations in relation to the population average. However, generic models interpolate subtle nuances and risk the loss of critical information, thereby compromising effective personalization of health care strategies. To acknowledge the substantial heterogeneity among patients and support the paradigm shift of precision medicine, we introduce Nearest Neighbor Normativity (N 3 ), which is a strategy to refine normativity evaluations in diverse and heterogeneous clinical study populations. We address current methodological shortcomings by accommodating several equally normative population prototypes, comparing individuals from multiple perspectives and designing specifically tailored control groups. Applied to brain structure in 36,896 individuals, the N 3 framework provides empirical evidence for its utility and significantly outperforms traditional methods in the detection of pathological alterations. Our results underscore N 3 's potential for individual assessments in medical practice, where norm deviations are not merely a benchmark, but an important metric supporting the realization of personalized patient care.

检测常模偏差是临床决策的基础,影响着我们有效诊断和治疗疾病的能力。目前的常模建模方法依赖于通用比较,并量化与人群平均值的偏差。然而,通用模型会对细微差别进行内插,有可能丢失关键信息,从而影响医疗策略的有效个性化。为了承认患者之间的巨大异质性并支持精准医疗的模式转变,我们引入了最近邻规范性(N3),这是一种在多样化和异质性临床研究人群中完善规范性评估的策略。我们解决了目前方法学上的缺陷,将几个同样规范的人群原型纳入其中,从多个角度对个体进行比较,并设计了专门定制的对照组。N3 框架应用于 36,896 人的大脑结构,为其实用性提供了经验证据,在病理改变的检测方面明显优于传统方法。我们的研究结果凸显了 N3 在医疗实践中进行个体评估的潜力,在医疗实践中,常模不仅是一个基准,还是一个动态工具,能适应错综复杂的个性化患者护理。
{"title":"Judged by your neighbors: Brain structural normativity profiles for large and heterogeneous samples.","authors":"Ramona Leenings, Nils R Winter, Jan Ernsting, Maximilian Konowski, Vincent Holstein, Susanne Meinert, Jennifer Spanagel, Carlotta Barkhau, Lukas Fisch, Janik Goltermann, Malte Frank Gerdes, Dominik Grotegerd, Elisabeth Johanna Leehr, Annette Peters, Lilian Krist, Stefan N Willich, Tobias Pischon, Henry Völzke, Johannes Haubold, Hans-Ulrich Kauczor, Thoralf Niendorf, Maike Frederike Richter, Udo Dannlowski, Klaus Berger, Xiaoyi Jiang, James Cole, Nils Opel, Tim Hahn","doi":"10.1101/2024.12.24.24319598","DOIUrl":"10.1101/2024.12.24.24319598","url":null,"abstract":"<p><p>The detection of norm deviations is fundamental to clinical decision making and impacts our ability to diagnose and treat diseases effectively. Current normative modeling approaches rely on generic comparisons and quantify deviations in relation to the population average. However, generic models interpolate subtle nuances and risk the loss of critical information, thereby compromising effective personalization of health care strategies. To acknowledge the substantial heterogeneity among patients and support the paradigm shift of precision medicine, we introduce Nearest Neighbor Normativity (N <sup>3</sup> ), which is a strategy to refine normativity evaluations in diverse and heterogeneous clinical study populations. We address current methodological shortcomings by accommodating several equally normative population prototypes, comparing individuals from multiple perspectives and designing specifically tailored control groups. Applied to brain structure in 36,896 individuals, the N <sup>3</sup> framework provides empirical evidence for its utility and significantly outperforms traditional methods in the detection of pathological alterations. Our results underscore N <sup>3</sup> 's potential for individual assessments in medical practice, where norm deviations are not merely a benchmark, but an important metric supporting the realization of personalized patient care.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exposotypes in Psychotic Disorders.
Pub Date : 2025-02-18 DOI: 10.1101/2025.02.14.25322306
Walid Yassin, Bryan Kromenacker, James B Green, Carol A Tamminga, Elisabetta C Del Re, Pegah Seif, Cuihua Xia, Ney Alliey-Rodriguez, Elliot S Gershon, Brett A Clementz, Godfrey D Pearlson, Sarah S Keedy, Elena I Ivleva, Scott Kristian Hill, Jennifer E McDowell, Matcheri S Keshavan

Psychiatry lags in adopting etiological approaches to diagnosis, prognosis, and outcome prediction compared to the rest of medicine. Etiological factors such as childhood trauma (CHT), substance use (SU), and socioeconomic status (SES) significantly affect psychotic disorder symptoms. This study applied an agnostic clustering approach to identify exposome clusters "Exposotypes (ETs)" and examine their relationship with clinical, cognitive, and functional outcomes. Using data from individuals with psychotic disorders (n=1,350), and controls (n=623), we assessed the relationship between the exposotypes and outcomes. Four exposotypes were identified: ET1 characterized by high CHT and SU; ET2, high CHT; ET3, high SU; ET4, low exposure. Compared to ET4, ET1 demonstrated higher positive and general symptoms, anxiety, depression, impulsivity, and mania; ET2 had higher anxiety, depression, and impulsivity; ET3 had better cognitive and functional outcomes with lower negative symptoms. Intracranial volume was largest in ET3, and smallest in ET2. No group differences in schizophrenia polygenic risk scores were found. The age of onset was 5 years earlier in ET1 than in ET4. These findings provide insight into the complex etiological interplay between trauma, and SU, as well as their unique effects on clinical symptoms, cognition, neurobiology, genetic risk, and functioning.

{"title":"Exposotypes in Psychotic Disorders.","authors":"Walid Yassin, Bryan Kromenacker, James B Green, Carol A Tamminga, Elisabetta C Del Re, Pegah Seif, Cuihua Xia, Ney Alliey-Rodriguez, Elliot S Gershon, Brett A Clementz, Godfrey D Pearlson, Sarah S Keedy, Elena I Ivleva, Scott Kristian Hill, Jennifer E McDowell, Matcheri S Keshavan","doi":"10.1101/2025.02.14.25322306","DOIUrl":"https://doi.org/10.1101/2025.02.14.25322306","url":null,"abstract":"<p><p>Psychiatry lags in adopting etiological approaches to diagnosis, prognosis, and outcome prediction compared to the rest of medicine. Etiological factors such as childhood trauma (CHT), substance use (SU), and socioeconomic status (SES) significantly affect psychotic disorder symptoms. This study applied an agnostic clustering approach to identify exposome clusters \"Exposotypes (ETs)\" and examine their relationship with clinical, cognitive, and functional outcomes. Using data from individuals with psychotic disorders (n=1,350), and controls (n=623), we assessed the relationship between the exposotypes and outcomes. Four exposotypes were identified: ET1 characterized by high CHT and SU; ET2, high CHT; ET3, high SU; ET4, low exposure. Compared to ET4, ET1 demonstrated higher positive and general symptoms, anxiety, depression, impulsivity, and mania; ET2 had higher anxiety, depression, and impulsivity; ET3 had better cognitive and functional outcomes with lower negative symptoms. Intracranial volume was largest in ET3, and smallest in ET2. No group differences in schizophrenia polygenic risk scores were found. The age of onset was 5 years earlier in ET1 than in ET4. These findings provide insight into the complex etiological interplay between trauma, and SU, as well as their unique effects on clinical symptoms, cognition, neurobiology, genetic risk, and functioning.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomewide Screen Identifies Peroxisomal Role in APOL1 Podocytopathy.
Pub Date : 2025-02-18 DOI: 10.1101/2025.02.15.25322241
Jiyoung Kim, Isaac Z Karel, Huijuan Song, Megan Dewalt, Shelley Orwick, Daelynn R Buelow, Kendyll Lee, Sergey V Brodsky, Angie Blissett, Ema Cocucci, Sharyn D Baker, Pei-Hui Lin, Navjot S Pabla, Sethu M Madhavan

The G1 and G2 variants of the APOL1 gene increase the risk of chronic kidney disease (CKD) in individuals of African descent. In the presence of secondary stressors such as inflammation and hypoxia, these gain-of-function variants can induce podocyte dysfunction and cell death through mechanisms that are not fully understood. To identify genes that influence the cytotoxic effects of APOL1 variants under hypoxic conditions, we conducted a comprehensive whole-genome RNA interference (RNAi) screen. We found that silencing several peroxisomal (PEX) genes significantly intensified the cytotoxicity associated with the G1 and G2 variants, revealing the previously unknown role of peroxisomes in APOL1-related cytotoxicity. Importantly, enhancing peroxisomal function through both genetic and pharmacological approaches led to a significant reduction in cytotoxicity linked to these variants. We also identified a peroxisomal targeting signal at the C-terminus of APOL1 that facilitates its translocation to peroxisomes during hypoxia, and mutations in this signal were found to reduce the cytotoxic effects of the variants. Collectively, our findings underscore the importance of peroxisomal function in the pathogenesis of CKD associated with APOL1 variants and suggest that targeting peroxisomes may represent an effective therapeutic strategy to mitigate CKD risk in vulnerable populations.

Translational statement: Peroxisomal function is necessary to protect from APOL1 (kidney risk variant) KRV-mediated cytotoxicity in the presence of hypoxia, and targeting peroxisomes may represent an effective therapeutic strategy to mitigate CKD risk.

{"title":"Genomewide Screen Identifies Peroxisomal Role in APOL1 Podocytopathy.","authors":"Jiyoung Kim, Isaac Z Karel, Huijuan Song, Megan Dewalt, Shelley Orwick, Daelynn R Buelow, Kendyll Lee, Sergey V Brodsky, Angie Blissett, Ema Cocucci, Sharyn D Baker, Pei-Hui Lin, Navjot S Pabla, Sethu M Madhavan","doi":"10.1101/2025.02.15.25322241","DOIUrl":"https://doi.org/10.1101/2025.02.15.25322241","url":null,"abstract":"<p><p>The G1 and G2 variants of the APOL1 gene increase the risk of chronic kidney disease (CKD) in individuals of African descent. In the presence of secondary stressors such as inflammation and hypoxia, these gain-of-function variants can induce podocyte dysfunction and cell death through mechanisms that are not fully understood. To identify genes that influence the cytotoxic effects of APOL1 variants under hypoxic conditions, we conducted a comprehensive whole-genome RNA interference (RNAi) screen. We found that silencing several peroxisomal (PEX) genes significantly intensified the cytotoxicity associated with the G1 and G2 variants, revealing the previously unknown role of peroxisomes in APOL1-related cytotoxicity. Importantly, enhancing peroxisomal function through both genetic and pharmacological approaches led to a significant reduction in cytotoxicity linked to these variants. We also identified a peroxisomal targeting signal at the C-terminus of APOL1 that facilitates its translocation to peroxisomes during hypoxia, and mutations in this signal were found to reduce the cytotoxic effects of the variants. Collectively, our findings underscore the importance of peroxisomal function in the pathogenesis of CKD associated with APOL1 variants and suggest that targeting peroxisomes may represent an effective therapeutic strategy to mitigate CKD risk in vulnerable populations.</p><p><strong>Translational statement: </strong>Peroxisomal function is necessary to protect from APOL1 (kidney risk variant) KRV-mediated cytotoxicity in the presence of hypoxia, and targeting peroxisomes may represent an effective therapeutic strategy to mitigate CKD risk.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Review of Psychological Resilience in the COVID-19 Responses: Current Research and Future Directions.
Pub Date : 2025-02-18 DOI: 10.1101/2025.02.15.25322337
Atena Pasha, Abdul-Hanan Inusah, Jannatun Nayem, Xiaoming Li, Shan Qiao

The COVID-19 pandemic has highlighted the importance of psychological resilience for well-being. However, no systematic review has been synthesizing global literature on this topic. This review examines psychological resilience across diverse populations, focusing on measurement, associated factors, and future public health preparedness strategies. Guided by the PRISMA, a thorough search of PsycINFO, PubMed, ScienceDirect, and Web of Science was conducted in February 2024 including empirical studies considering psychological resilience during the COVID-19 pandemic published in peer-reviewed English journals from 2020 to 2024, using search terms relevant to psychological resilience and COVID-19. Sixty-eight studies included, mostly using CD-RISC to measure psychological resilience. Multiple factors at various socio-ecological levels were associated with psychological resilience. Effective strategies in promoting resilience included promoting social connectedness through government policies and health communication campaigns and implementing personalized interventions such as telehealth services, resilience-training programs, and mindfulness-based interventions. For preparedness for future public health crises, long-term strategies emphasized investments in mental health services, resilience-building activities, and providing robust support for mental health across diverse populations. Community and educational initiatives should focus on mental health promotion programs in colleges and schools and life skills training to improve interpersonal skills and job crafting. Technological solutions like remote consultations, mHealth applications, and telehealth were also recommended. This review suggests that improving preparedness for future public health crises requires prioritizing investments in mental health services, resilience-building activities, and mHealth applications. These insights provide a foundational resource for research, policy, and interventions to strengthen resilience globally at individual, community, and structural levels.

{"title":"A Systematic Review of Psychological Resilience in the COVID-19 Responses: Current Research and Future Directions.","authors":"Atena Pasha, Abdul-Hanan Inusah, Jannatun Nayem, Xiaoming Li, Shan Qiao","doi":"10.1101/2025.02.15.25322337","DOIUrl":"https://doi.org/10.1101/2025.02.15.25322337","url":null,"abstract":"<p><p>The COVID-19 pandemic has highlighted the importance of psychological resilience for well-being. However, no systematic review has been synthesizing global literature on this topic. This review examines psychological resilience across diverse populations, focusing on measurement, associated factors, and future public health preparedness strategies. Guided by the PRISMA, a thorough search of PsycINFO, PubMed, ScienceDirect, and Web of Science was conducted in February 2024 including empirical studies considering psychological resilience during the COVID-19 pandemic published in peer-reviewed English journals from 2020 to 2024, using search terms relevant to psychological resilience and COVID-19. Sixty-eight studies included, mostly using CD-RISC to measure psychological resilience. Multiple factors at various socio-ecological levels were associated with psychological resilience. Effective strategies in promoting resilience included promoting social connectedness through government policies and health communication campaigns and implementing personalized interventions such as telehealth services, resilience-training programs, and mindfulness-based interventions. For preparedness for future public health crises, long-term strategies emphasized investments in mental health services, resilience-building activities, and providing robust support for mental health across diverse populations. Community and educational initiatives should focus on mental health promotion programs in colleges and schools and life skills training to improve interpersonal skills and job crafting. Technological solutions like remote consultations, mHealth applications, and telehealth were also recommended. This review suggests that improving preparedness for future public health crises requires prioritizing investments in mental health services, resilience-building activities, and mHealth applications. These insights provide a foundational resource for research, policy, and interventions to strengthen resilience globally at individual, community, and structural levels.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining Perinatal Regionalization in Practice: A Network Analysis of Maternal Transport in Georgia.
Pub Date : 2025-02-18 DOI: 10.1101/2025.02.14.25322280
Jingyu Li, Stephanie M Radke, Lauren N Steimle

Objective: The primary objective was to use network analysis to characterize maternal transport patterns in the state of Georgia and compare them with the state's designated perinatal regions (DPRs).

Study design: Using 2017-2022 birth records in Georgia, we constructed network graphs of maternal transport routes among obstetric facilities. We used multivariate logistic regression to identify factors associated with inter-DPR transports. We applied a community-detection algorithm to cluster facilities and compared the clusters to Georgia's DPRs.

Results: Among 774 639 deliveries, 2 757 (0.36%) involved transports among obstetric facilities. 8 facility clusters were identified and strongly aligned with DPRs (p < 0.001). Inter-DRP transports tended to occur between neighboring DPRs and between facilities belonging to the same healthcare system (p < 0.001).

Conclusion: Network analysis reveals patterns of maternal transports among obstetric facilities. States can improve the design of perinatal regionalization systems by formalizing existing partnership among obstetric facilities.

{"title":"Examining Perinatal Regionalization in Practice: A Network Analysis of Maternal Transport in Georgia.","authors":"Jingyu Li, Stephanie M Radke, Lauren N Steimle","doi":"10.1101/2025.02.14.25322280","DOIUrl":"https://doi.org/10.1101/2025.02.14.25322280","url":null,"abstract":"<p><strong>Objective: </strong>The primary objective was to use network analysis to characterize maternal transport patterns in the state of Georgia and compare them with the state's designated perinatal regions (DPRs).</p><p><strong>Study design: </strong>Using 2017-2022 birth records in Georgia, we constructed network graphs of maternal transport routes among obstetric facilities. We used multivariate logistic regression to identify factors associated with inter-DPR transports. We applied a community-detection algorithm to cluster facilities and compared the clusters to Georgia's DPRs.</p><p><strong>Results: </strong>Among 774 639 deliveries, 2 757 (0.36%) involved transports among obstetric facilities. 8 facility clusters were identified and strongly aligned with DPRs (p < 0.001). Inter-DRP transports tended to occur between neighboring DPRs and between facilities belonging to the same healthcare system (p < 0.001).</p><p><strong>Conclusion: </strong>Network analysis reveals patterns of maternal transports among obstetric facilities. States can improve the design of perinatal regionalization systems by formalizing existing partnership among obstetric facilities.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875245/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
medRxiv : the preprint server for health sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1